Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 10/14/2016
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / -||UN / IM|
Administered by: Other Purchased by: Other
Symptoms: Blindness transient, Blindness unilateral, Deafness, Mobility decreased
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: No other medications
Current Illness: Unknown
Diagnostic Lab Data:
CDC 'Split Type': WAES1606COL001114
Write-up:This spontaneous report was received from a journalist regarding a female patient of unknown age. The patient''s medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL (via intramuscular route, dose and lot # were not reported). On an unknown date, the patient experienced immobility as she could not move her legs. The patient must have been in a wheelchair. On an unknown date, the patient experienced unilateral blindness, blindness transient (three times) and deafness. The outcome of the event "could not move her legs (immobility)", unilateral blindness and deafness was reported as recovered/resolved (on an unspecified day). The outcome of the event blindness transient was reported as not recovered/not resolved. The relatedness between the events and the therapy with GARDASIL was not provided. The reporter considered the events "could not move her legs (immobility)", unilateral blindness, and deafness to be medically significant and disabling. The reporter considered the event of blindness transient to be medically significant. This is one of several reports received from the same source. Additional information is not expected as no follow up is required.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166